
Mega Doctor News
Medical News Today
- There are several risk factors for dementia, including type 2 diabetes and obesity.
- A new study reports that semaglutide — the active ingredient in GLP-1 medications Ozempic and Wegovy for type 2 diabetes and weight loss — may help lower dementia risk in people with type 2 diabetes.
- Researchers say semaglutide targets several dementia risk factors and is anti-inflammatory, which could explain this benefit to brain health.
According to Alzheimer’s Disease International, as of 2020, there were over 55 million peopleliving with dementia, with that number expected to rise to 78 million by 2030.
Follow the link below to Medical News Today to read the full story:
Information source: https://www.medicalnewstoday.com